Bharat Bio successfully completes Phase III trials of new oral...

Dununu.com Dununu

Commandité

Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol

RSS Feed National

Posté

147

Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.

Read Full Article

Connectez-vous pour aimer, partager et commenter!

Economic Digest: Nepal’s Business News in a Nutshell

KATHMANDU: Economic Digest offers a concise yet comprehensive overview of significant business...

Par 0 6

'He’s winning it' – Rishabh Pant drops Wimbledon 2025 prediction – Watch

Rishabh Pant, the dynamic Indian wicketkeeper-batter, made his Wimbledon debut amidst a break...

Par 0 23

One killed, another injured in lightning strike in Taplejung

TAPLEJUNG: A man has died and another has been injured after being struck by lightning in...

Par 0 33

Neena Gupta opens up about her FIRST husband

Neena Gupta reminisced about her early romances. Her first love was an IIT student, whom she...

Par 0 36

RCB stampede chargesheet only after HC nod

Par 0 42